Daniel L. Kacian

Director Técnico/Científico/I+D en Gen-Probe, Inc. .

77 años

Consumer Services

Health Technology

Perfil

Daniel L.
Kacian is currently the Chief Scientist & Executive Vice President at Gen-Probe, Inc. He received his undergraduate degree from Case Western Reserve University and his graduate and doctorate degrees from the University of Illinois.
He also received a doctorate degree from the University of Miami in 1978.

Cargos activos de Daniel L. Kacian

Empresas	Cargo	Inicio
Gen-Probe, Inc. Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA.	Director Técnico/Científico/I+D	01/01/1985

Todos los cargos activos de Daniel L. Kacian

Formación de Daniel L. Kacian.

University of Illinois	Doctorate Degree
University of Miami	Doctorate Degree
Case Western Reserve University	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Daniel L. Kacian.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
Gen-Probe, Inc. Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA.	Health Technology